sas version 6.4 (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
sas version 6.4
Sas Version 6.4, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sas+version+6%2E4/sas+version+9+4/pmc11304690-156-25-42
Average 90 stars, based on 1 article reviews
Sas Version 6.4, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sas+version+6%2E4/sas+version+9+4/pmc11304690-156-25-42
Average 90 stars, based on 1 article reviews
sas version 6.4 - by Bioz Stars,
2026-11
90/100 stars
Images
1) Product Images from "Outpatient elective induction of labour at 39 weeks’ gestation (HOME INDUCTION): an open-label, randomised, controlled, phase III, non-inferiority trial"
Article Title: Outpatient elective induction of labour at 39 weeks’ gestation (HOME INDUCTION): an open-label, randomised, controlled, phase III, non-inferiority trial
Journal: eClinicalMedicine
doi: 10.1016/j.eclinm.2024.102741
Figure Legend Snippet: Maternal and neonatal outcomes (per protocol population).
Techniques Used: Infection
Figure Legend Snippet: Return to hospital visit, second induction modality and delivery (Per Protocol Population).
Techniques Used:
Figure Legend Snippet: Patient Satisfaction Questionnaire data.
Techniques Used:
Related Articles
Blocking Assay:Article Title: Safety and efficacy of tramadol in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. Article Snippet: Purpose: To evaluate the efficacy and safety of a new serotonergic centrally acting drug tramadol in delaying ejaculation in patients with premature ejaculation.. Materials and Methods: Sixty-four potent men with premature ejaculation were randomly assigned to receive 50 mg tramadol (group 1, n = 32) or placebo (group 2, n = 32) approximately 2 hours before planned sexual activity, for 8 weeks.. Pretreatment evaluation included history and physical examination, intravaginal ejaculatory latency time, International Index of Erectile Function, and Meares-Stamey test. Article Title: Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort Article Snippet: Marsico Lung Institute/Cystic Fibrosis and Pulmonary Research Center (G Radicioni PhD, A Ceppe MS, A A Ford MsPH, E Ozkan MD, W K O’Neal PhD, Prof R C Boucher MD, Prof M Kesimer PhD), and Center for Environmental Medicine, Asthma, and Lung Biology, Division of Allergy and Immunology (Prof N E Alexis PhD), University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, Columbia University Medical Center, New York, NY, USA (Prof R G Barr MD); Department of Epidemiology, Mailman School of Public Health at Columbia University, New York, NY, USA (Prof R G Barr); Center for Genetics and Genomic Medicine, University of Arizona Health Sciences, Tucson, AZ, USA (Prof E R Bleecker MD); Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of San Francisco Medical Center, University of California San Francisco, San Francisco, CA, USA (S A Christenson MD, Prof P G Woodruff MD); Department of Medicine and Physiology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA (Prof C B Cooper MD); Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, MI, USA (Prof M K Han MD); Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA (Prof N N Hansel MD); Section on Pulmonary, Critical Care, Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort Article Title: Insurance Differences in Preventive Care Use and Adverse Birth Outcomes Among Pregnant Women in a Medicaid Nonexpansion State: A Retrospective Cohort Study Article Snippet: Analyses were conducted using Article Title: Human Exposure to Anaplasma phagocytophilum in Two Cities of Northwestern Morocco Article Snippet: A statistical analysis was performed using Article Title: Outpatient elective induction of labour at 39 weeks’ gestation (HOME INDUCTION): an open-label, randomised, controlled, phase III, non-inferiority trial Article Snippet: Trial participants were randomised using simple random allocation to either Dilapan-S for 12 h (D12), Dilapan-S for 24 h (D24), or Article Title: A randomised open-label trial to assess outpatient induction of labour (HOMEIND) and compare efficacy of Propess vs Dilapan-S® for induction of labour at 39 weeks' gestation in normal risk nulliparous women: study protocol for a randomised controlled trial. Article Snippet: Patients will be randomised using simple random allocation to either Dilapan-S® (12-h insertion or 24-h insertion) or Propess in a 1:1:1 ratio using a Article Title: Detection of Anaplasma spp. and Ehrlichia spp. anibodies, and Dirofilaria immitis antigens in dogs from seven locations of Morocco. Article Snippet: In Morocco no data has been published on canine exposure to Anaplasma spp., Borrrelia burgdorferi, and Ehrlichia spp., and only one report is available on the occurrence of Dirofilaria immitis in dogs.. Therefore, the aim of this study was to collect current data on the canine exposure to these vectorborne pathogens (VBPs) in Morocco.. A total of 217 urban (n=57), rural (n=110) and military (n=50) dogs from seven Moroccan locations were screened for Anaplasma spp., B. burgdorferi and Ehrlichia spp. antibodies and for D. immitis antigens using a commercial in-clinic ELISA test. Article Title: Screening Colonoscopy Findings Are Associated With Noncolorectal Cancer Mortality Article Snippet: Study database management was performed using Software:Article Title: Safety and efficacy of tramadol in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. Article Snippet: Purpose: To evaluate the efficacy and safety of a new serotonergic centrally acting drug tramadol in delaying ejaculation in patients with premature ejaculation.. Materials and Methods: Sixty-four potent men with premature ejaculation were randomly assigned to receive 50 mg tramadol (group 1, n = 32) or placebo (group 2, n = 32) approximately 2 hours before planned sexual activity, for 8 weeks.. Pretreatment evaluation included history and physical examination, intravaginal ejaculatory latency time, International Index of Erectile Function, and Meares-Stamey test. Article Title: Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort Article Snippet: Marsico Lung Institute/Cystic Fibrosis and Pulmonary Research Center (G Radicioni PhD, A Ceppe MS, A A Ford MsPH, E Ozkan MD, W K O’Neal PhD, Prof R C Boucher MD, Prof M Kesimer PhD), and Center for Environmental Medicine, Asthma, and Lung Biology, Division of Allergy and Immunology (Prof N E Alexis PhD), University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, Columbia University Medical Center, New York, NY, USA (Prof R G Barr MD); Department of Epidemiology, Mailman School of Public Health at Columbia University, New York, NY, USA (Prof R G Barr); Center for Genetics and Genomic Medicine, University of Arizona Health Sciences, Tucson, AZ, USA (Prof E R Bleecker MD); Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of San Francisco Medical Center, University of California San Francisco, San Francisco, CA, USA (S A Christenson MD, Prof P G Woodruff MD); Department of Medicine and Physiology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA (Prof C B Cooper MD); Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, MI, USA (Prof M K Han MD); Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA (Prof N N Hansel MD); Section on Pulmonary, Critical Care, Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort Article Title: Insurance Differences in Preventive Care Use and Adverse Birth Outcomes Among Pregnant Women in a Medicaid Nonexpansion State: A Retrospective Cohort Study Article Snippet: Analyses were conducted using Article Title: Human Exposure to Anaplasma phagocytophilum in Two Cities of Northwestern Morocco Article Snippet: A statistical analysis was performed using Article Title: Outpatient elective induction of labour at 39 weeks’ gestation (HOME INDUCTION): an open-label, randomised, controlled, phase III, non-inferiority trial Article Snippet: Trial participants were randomised using simple random allocation to either Dilapan-S for 12 h (D12), Dilapan-S for 24 h (D24), or Article Title: A randomised open-label trial to assess outpatient induction of labour (HOMEIND) and compare efficacy of Propess vs Dilapan-S® for induction of labour at 39 weeks' gestation in normal risk nulliparous women: study protocol for a randomised controlled trial. Article Snippet: Patients will be randomised using simple random allocation to either Dilapan-S® (12-h insertion or 24-h insertion) or Propess in a 1:1:1 ratio using a Article Title: Detection of Anaplasma spp. and Ehrlichia spp. anibodies, and Dirofilaria immitis antigens in dogs from seven locations of Morocco. Article Snippet: In Morocco no data has been published on canine exposure to Anaplasma spp., Borrrelia burgdorferi, and Ehrlichia spp., and only one report is available on the occurrence of Dirofilaria immitis in dogs.. Therefore, the aim of this study was to collect current data on the canine exposure to these vectorborne pathogens (VBPs) in Morocco.. A total of 217 urban (n=57), rural (n=110) and military (n=50) dogs from seven Moroccan locations were screened for Anaplasma spp., B. burgdorferi and Ehrlichia spp. antibodies and for D. immitis antigens using a commercial in-clinic ELISA test. Article Title: Screening Colonoscopy Findings Are Associated With Noncolorectal Cancer Mortality Article Snippet: Study database management was performed using Infection:Article Title: Safety and efficacy of tramadol in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. Article Snippet: Purpose: To evaluate the efficacy and safety of a new serotonergic centrally acting drug tramadol in delaying ejaculation in patients with premature ejaculation.. Materials and Methods: Sixty-four potent men with premature ejaculation were randomly assigned to receive 50 mg tramadol (group 1, n = 32) or placebo (group 2, n = 32) approximately 2 hours before planned sexual activity, for 8 weeks.. Pretreatment evaluation included history and physical examination, intravaginal ejaculatory latency time, International Index of Erectile Function, and Meares-Stamey test. Article Title: Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort Article Snippet: Marsico Lung Institute/Cystic Fibrosis and Pulmonary Research Center (G Radicioni PhD, A Ceppe MS, A A Ford MsPH, E Ozkan MD, W K O’Neal PhD, Prof R C Boucher MD, Prof M Kesimer PhD), and Center for Environmental Medicine, Asthma, and Lung Biology, Division of Allergy and Immunology (Prof N E Alexis PhD), University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, Columbia University Medical Center, New York, NY, USA (Prof R G Barr MD); Department of Epidemiology, Mailman School of Public Health at Columbia University, New York, NY, USA (Prof R G Barr); Center for Genetics and Genomic Medicine, University of Arizona Health Sciences, Tucson, AZ, USA (Prof E R Bleecker MD); Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of San Francisco Medical Center, University of California San Francisco, San Francisco, CA, USA (S A Christenson MD, Prof P G Woodruff MD); Department of Medicine and Physiology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA (Prof C B Cooper MD); Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, MI, USA (Prof M K Han MD); Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA (Prof N N Hansel MD); Section on Pulmonary, Critical Care, Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort Article Title: Insurance Differences in Preventive Care Use and Adverse Birth Outcomes Among Pregnant Women in a Medicaid Nonexpansion State: A Retrospective Cohort Study Article Snippet: Analyses were conducted using Article Title: Human Exposure to Anaplasma phagocytophilum in Two Cities of Northwestern Morocco Article Snippet: A statistical analysis was performed using Article Title: Outpatient elective induction of labour at 39 weeks’ gestation (HOME INDUCTION): an open-label, randomised, controlled, phase III, non-inferiority trial Article Snippet: Trial participants were randomised using simple random allocation to either Dilapan-S for 12 h (D12), Dilapan-S for 24 h (D24), or Article Title: A randomised open-label trial to assess outpatient induction of labour (HOMEIND) and compare efficacy of Propess vs Dilapan-S® for induction of labour at 39 weeks' gestation in normal risk nulliparous women: study protocol for a randomised controlled trial. Article Snippet: Patients will be randomised using simple random allocation to either Dilapan-S® (12-h insertion or 24-h insertion) or Propess in a 1:1:1 ratio using a Article Title: Detection of Anaplasma spp. and Ehrlichia spp. anibodies, and Dirofilaria immitis antigens in dogs from seven locations of Morocco. Article Snippet: In Morocco no data has been published on canine exposure to Anaplasma spp., Borrrelia burgdorferi, and Ehrlichia spp., and only one report is available on the occurrence of Dirofilaria immitis in dogs.. Therefore, the aim of this study was to collect current data on the canine exposure to these vectorborne pathogens (VBPs) in Morocco.. A total of 217 urban (n=57), rural (n=110) and military (n=50) dogs from seven Moroccan locations were screened for Anaplasma spp., B. burgdorferi and Ehrlichia spp. antibodies and for D. immitis antigens using a commercial in-clinic ELISA test. Article Title: Screening Colonoscopy Findings Are Associated With Noncolorectal Cancer Mortality Article Snippet: Study database management was performed using |